Here are five updates on GI companies from the past week.
The Motley Fool examined possible reasons behind why Exact Sciences' stock has fallen 20 percent in 2018, after nearly tripling in value in 2017.
Fujifilm Medical Systems USA is partnering with Fight Colorectal Cancer to support its One Million Strong campaign.
Motus GI's colonoscopy preparation system Pure-Vu received European CE mark approval.
Washington, D.C.-based Capital Digestive Care deployed gMed's cloud-based EHR system, gGastro Cloud.
Volition RX announced interim results from its asymptomatic colorectal cancer frontline screening study, finding it successfully detected stage 1 CRC 80 percent of the time.